As shown by correlation analysis, glioma-derived ANXA2 expression was positively correlated with biomarker gene expression in all six immune cell types in the TCGA and CGGA datasets (Fig. 8A,B). This evidence concerns the gene ANXA2 and central nervous system cancer.